KPT-185 – 25 mg

Brand:
Cayman
CAS:
1333151-73-7
Storage:
-20
UN-No:
De Minimis - 3077 / 9

KPT-185 is an inhibitor of Exportin 1 (XPO1/CRM1) with anticancer activity.{47263,31566} It reduces proliferation in a panel of patient-derived acute myeloid leukemia cells (IC50s = 100-500 nM).{47263} KPT-185 induces cell cycle arrest in the G1 phase and apoptosis in MOLT-4 T cell acute lymphoblastic leukemia cells and in a panel of six non-small cell lung cancer (NSCLC) cell lines in a time- and dose-dependent manner.{31566,47264}  

 

Available on backorder

SKU: 26074 - 25 mg Category:

Description

An inhibitor of XPO1/CRM1; reduces proliferation in a panel of patient-derived acute myeloid leukemia cells (IC50s = 100-500 nM); induces cell cycle arrest in the G1 phase and apoptosis in MOLT-4 T cell acute lymphoblastic leukemia cells and in a panel of six NSCLC cell lines


Formal name: 3-[3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2Z-propenoic acid, 1-methylethyl ester

Synonyms: 

Molecular weight: 355.3

CAS: 1333151-73-7

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Death|Apoptosis